P74 Guselkumab clinical super-response is associated with faster normalization of blood and skin pathology: data from the Phase 3b GUIDE trial

出处
期刊:British Journal of Dermatology [Oxford University Press]
卷期号:191 (Supplement_3)
标识
DOI:10.1093/bjd/ljae360.104
摘要

Abstract The ongoing GUIDE trial (NCT03818035) examines the clinical and immunological impact of an extended dosing interval of guselkumab [an interleukin (IL)-23p19 subunit inhibitor] in patients with moderate-to-severe plaque-type psoriasis. A mechanistic substudy was conducted to explore the molecular differences in the skin and blood of ‘super-responder’ (SRe) and non-SRe patients. SRes were defined as patients achieving a psoriasis area and severity index (PASI) = 0 at both Week [W]20 and W28 following guselkumab treatment. RNA-sequencing was performed on non-lesional (at W0) and lesional skin samples (at W0, W4, W28, and W68) along with serum analyses of matching timepoints. Published gene sets related to psoriasis skin and cytokine-stimulated keratinocytes were used for gene set variation analysis. At W0, ∼1100 protein-coding transcripts were upregulated in lesional vs. non-lesional skin, and ∼3000 protein-coding transcripts were downregulated in lesional vs. non-lesional skin. Following treatment with guselkumab, robust pharmacodynamic changes were observed for immune- and psoriasis inflammation-related gene signatures. Faster changes were observed in SRes vs. non-SRes. Signatures related to psoriasis skin inflammation, IL-17-stimulated keratinocyte response, T-helper (Th)17 cells, and many keratinocyte subtypes (differentiated, proliferating and inflamed keratinocytes) were more significantly reduced in SRes vs. non-SRes as early as W4. By W28, all signatures that were upregulated at baseline in lesional vs. non-lesional skin were normalized in SRes, including molecular scar skin and Th17 pathway signatures. In contrast, among non-SRes, molecular scar and immune-cell-regulated signatures (including macrophage, Th22, mucosal-associated invariant T cells, and CD4+ T cells) were <75% normalized at W28. In both SRes and non-SRes, signatures initially downregulated in lesional vs. non-lesional skin at W0, including those for adipocytes, smooth muscles, meta-analysis-derived psoriasis downregulated genes, and IL-17-stimulated KC downregulated genes, represent the few signatures that did not return to non-lesional skin levels after 68 weeks of guselkumab treatment. Consistent with the effect of guselkumab on inflammatory processes in the skin as observed via RNA sequencing, guselkumab treatment decreased the serum levels of several inflammatory mediators as early as W4. The levels of IL-17A, IL-17F and IL-22 were comparable in SRes and non-SRes, while the reduction in beta defensin-2 level was more pronounced in SRes at W4 and W28. These reductions were maintained to W68. In summary, molecular analyses of SRes and non-SRes in the GUIDE clinical trial show kinetic and quantitative differences in the response to guselkumab treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研小白菜完成签到,获得积分20
1秒前
333发布了新的文献求助10
2秒前
2秒前
2秒前
童菲发布了新的文献求助10
2秒前
菜黎明发布了新的文献求助10
2秒前
lee完成签到,获得积分10
3秒前
LiM完成签到,获得积分10
3秒前
嘻嘻哈哈的应助被五月天采纳,获得10
4秒前
4秒前
搜集达人的应助被莫北采纳,获得10
4秒前
5秒前
5秒前
如意康发布了新的文献求助200
5秒前
杏乙完成签到 ,获得积分10
6秒前
6秒前
失望的山谷完成签到,获得积分20
6秒前
6秒前
李秉烛完成签到,获得积分10
6秒前
brebre完成签到 ,获得积分10
7秒前
luochenghao发布了新的文献求助10
7秒前
法瓷双厨完成签到,获得积分10
7秒前
7秒前
eisenchen完成签到,获得积分10
7秒前
蜗牛完成签到,获得积分10
7秒前
8秒前
xxxx666g发布了新的文献求助10
8秒前
ding的应助被malele采纳,获得10
8秒前
林莹完成签到,获得积分10
9秒前
9秒前
逢桥完成签到,获得积分10
9秒前
hhy发布了新的文献求助10
9秒前
9秒前
耿强完成签到,获得积分10
10秒前
10秒前
搜集达人的应助被Lula采纳,获得10
10秒前
KYTYYDS发布了新的文献求助10
10秒前
liwen发布了新的文献求助10
10秒前
11秒前
戴景轩发布了新的文献求助10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160526
求助须知:如何正确求助?哪些是违规求助? 9555475
关于积分的说明 21728510
捐赠科研通 7750342
什么是DOI,文献DOI怎么找? 3427395
关于科研通互助平台的介绍 2552448
邀请新用户注册赠送积分活动 2471795